SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2015 / Cilt: 24 - Sayı: 0

18F-FDG PET/CT Findings of a Patient with Wegener's Granulomatosis Before and After Therapy

ELİF ÖZDEMİR
Nilüfer YILDIRIM POYRAZ
Ayşegül ŞENTÜRK
Ebru UZ
Mutlay KESKİN
Levent YÜKSEL
Zuhal KANDEMİR
ŞEYDA TÜRKÖLMEZ
Pages
1–3
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The increased FDG uptake of these lesions substantially regressed following treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Wegener's granulomatosis (WG) is a rare form of systemic vasculitis that primarily involves the small-to-medium sized vessels and affects both the kidneys and the upper and lower respiratory tract.
📊
Key Findings & Data:In this case report, FDG PET/CT findings of bilateral hypermetabolic lung lesions that mimic malignancy in a patient with WG are presented.
💡
Conclusion & Impact:The increased FDG uptake of these lesions substantially regressed following treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Wegener's granulomatosis (WG) is a rare form of systemic vasculitis that primarily involves the small-to-medium sized vessels and affects both the kidneys and the upper and lower respiratory tract. In this case report, FDG PET/CT findings of bilateral hypermetabolic lung lesions that mimic malignancy in a patient with WG are presented. The hypermetabolic lesions completely disappeared on follow-up PET/CT scan after treatment with cyclophosphamide. The increased FDG uptake of these lesions substantially regressed following treatment

Özet

Wegener granülomatozu (WG) nadir görülen bir sistemik vaskülit olup; orta-büyük damarları tutar ve üst-alt solunum sistemini ve böbrekleri etkiler. Bu olgu sunumunda maligniteyi taklit eden bilateral hipermetabolik akciğer kitleleri izlenen bir WG olgusunun FDG PET/BT görüntüleme bulguları sunulmuştur. WG lezyonlarında izlenen artmış FDG tutulumlarının tedavi sonrası kaybolduğu izlenmiştir

🔖

Cite This Article

ÖZDEMİR, E., POYRAZ, N. Y., ŞENTÜRK, A., UZ, E., KESKİN, M., YÜKSEL, L., KANDEMİR, Z., TÜRKÖLMEZ, Ş. (2015). 18F-FDG PET/CT Findings of a Patient with Wegener's Granulomatosis Before and After Therapy. Molecular Imaging and Radionuclide Therapy, Cilt: 24 - Sayı: 0, 1–3. https://ajindex.com/articles/295153

References (13)

  1. Woywodt A, Matteson EL. Wegener's granulomatosi--probing the untold past of the man behind the eponym. Rheumatology (Oxford) 2006;45:1303-1306.
  2. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-498.
  3. Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003;63:670-677.
  4. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003;30:1305-1313.
  5. Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M, Mimori A, Kubota K. Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/ computed tomography.Ann Nucl Med 2013;27:209-216.
  6. Sağer S, Yılmaz S, Ozhan M, Halaç M, Ergül N, Ciftci H, Cermik TF. F-18 FDG PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy. Mol Imaging Radionucl Ther 2012;21:32-34.
  7. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-498.
  8. Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2- deoxy-D-glucose avidity on positron emission tomography/computed tomography. Cancer 2008;113:3213-3221.
  9. Ananthakrishnan L, Sharma N, Kanne JP. Wegener's granulomatosis in the chest: high-resolution CT findings. AJR Am J Roentgenol 2009;192:676-682.
  10. Martinez F, Chung JH, Digumarthy SR, Kanne JP, Abbott GF, Shepard JA, Mark EJ, Sharma A. Common and uncommon manifestations of Wegener granulomatosis at chest CT: radiologic-pathologic correlation. Radiographics 2012;32:51-69.
  11. Ueda N, Inoue Y, Himeji D, Shimao Y, Oryoji K, Mitoma H, Arinobu Y, Niiro H, Tsukamoto H, Horiuchi T, Ueda A, Akashi K. Wegener's granulomatosis detected initially by integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Mod Rheumatol 2010;20:205-209.
  12. Ozmen O, Tatci E, Gokcek A, Koksal D, Dadali Y, Ozaydin E, Arslan N. Integration of 2-deoxy-2-(18F) fluoro-D-glucose PET/CT into clinical management of patients with Wegener's granulomatosis. Ann Nucl Med 2013;27:907-915
  13. Beggs AD, Hain SF. F-18 FDG-positron emiss